{'fraction_non_alphanumeric': 0.028894472361809045, 'fraction_numerical': 0.010050251256281407, 'mean_word_length': 4.966292134831461, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.

The effect of naloxone and methadone on the systemic release of arginine vasopressin (AVP) was studied in six conscious dogs. After i.v. methadone administration (1 mg/kg b.wt.) plasma AVP levels rose significantly to a mean maximum value of 102.8 +/- 18.8 pg/ml at 15 min postinjection. Plasma sodium and plasma osmolality did not change significantly, whereas plasma potassium decreased significantly. Blood gas variables showed the development of a slight respiratory acidosis. Mean arterial blood pressure increased and heart rate decreased, both significantly, after methadone administration. Naloxone (0.1 mg/kg b.wt.) administered i.v., 15 min before methadone, prevented the changes in plasma AVP levels as well as other variables, with the exception of the heart rate. Naloxone administration itself did not induce changes in any variable recorded. The dose-response study showed increasing plasma AVP levels upon administration of increasing doses of methadone above the 0.5 mg/kg level. On account of the magnitude of response and the lack of changes in biochemical and hemodynamic variables sufficient to explain the documented AVP response, we conclude that methadone exerts a stimulatory influence on the systemic release of AVP. We consider the documented release of AVP to be a direct effect of the methadone administration, on account of the findings from the dose-response study and on account of the total blockade of the response after naloxone administration before methadone.